Bioxytran (BIXT) Share-based Compensation (2010 - 2026)
Bioxytran (BIXT) recorded Share-based Compensation of $30,515 in Q2 2026, up 39.0% from $21,955 a year earlier but down 14.9% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Share-based Compensation (2010 - 2026) Analysis & Trends
On a TTM basis, Bioxytran's Share-based Compensation came in at $123,497 as of Jun 30, 2026, down 9.2% year-over-year; for FY2025, it was $170,399, down 14.7% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of -7.2% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $199,682 in FY2024 (+126.7%), $88,100 in FY2023 (-37.1%), $139,982 in FY2022 (-76.0%) and $582,862 in FY2021 (+135.2%).
- Quarterly Share-based Compensation has ranged from -$243,590 in Q4 2021 to $168,410 in Q1 2024 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in four of the last seven quarters, with growth averaging 64.1%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 342.2% in Q4 2025, against a decline of 99.2% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $35,838 (Q1 2026), $63,645 (Q4 2025) and -$6,501 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | 30,515.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30,515.00 |
| Mar 31, 2026 | 35,838.00 |
| Dec 31, 2025 | 63,645.00 |
| Sep 30, 2025 | -6,501.00 |
| Jun 30, 2025 | 21,955.00 |
| Mar 31, 2025 | 91,300.00 |
| Dec 31, 2024 | 14,394.00 |
| Sep 30, 2024 | 8,416.00 |
| Jun 30, 2024 | 10,691.00 |
| Mar 31, 2024 | 168,410.00 |
| Dec 31, 2023 | 5,572.00 |
| Sep 30, 2023 | 81,318.00 |
| Jun 30, 2023 | 360.00 |
| Mar 31, 2023 | 850.00 |
| Dec 31, 2022 | -2,648.00 |
| Sep 30, 2022 | 73,507.00 |
| Jun 30, 2022 | 46,723.00 |
| Mar 31, 2022 | 22,400.00 |
| Dec 31, 2021 | -243,590.00 |
| Sep 30, 2021 | 844.00 |
API Access
Bioxytran Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();